Axsome Therapeutics
Axsome Therapeutics
Agent45Agent Readiness: 45/100. Above median. Measured by StartupHub.ai. Median 41.Biopharmaceutical company developing novel therapies for the management of central nervous system (CNS) disorders.
About
Axsome Therapeutics is a commercial-stage biopharmaceutical company focused on developing and delivering innovative therapies for central nervous system (CNS) conditions. The company leverages a multi-mechanistic approach and the 505(b)(2) regulatory pathway to address significant unmet medical needs in areas such as depression, Alzheimer's disease, and narcolepsy.
Key facts
At-a-glance profile data
- Website
- axsome.com
- Headquarters
- New York, United States
- Founded
- 2012
- Total funding
- -
- Business model
- B2B
Tech stack
Detected on axsome.com, last scanned 18 Sept 2026. Run your own scan
- Frontend
- jQuery
- Analytics
- Google Tag Manager
- SEO
- Yoast SEO
- CMS / Builders
- WordPress
- CDN
- Cloudflare
- Email provider
- Microsoft 365
- Cookie consent
- OneTrust
Add first review